David Bissig
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
David Bissig has a total of 91 co-authors. Here are the top co-authors by number of shared publications:
- Bruce A. Berkowitz
Department of Ophthalmology, Visual and Anatomical Sciences, Wayne State University School of Medicine, Detroit, Michigan, United States
15 shared publications Robin Roberts
Dept. Of Ophthalmology, Wayne State University School of Medicine, Detroit, MI, USA
13 shared publicationsBruce A. Berkowitz
Department of Anatomy and Cell Biology, Wayne State University School of Medicine, Detroit, MI, USA
6 shared publicationsMarius Gradianu
From the Departments of Anatomy and Cell Biology and
3 shared publicationsTimothy S. Kern
Department of Medicine, School of Medicine, Case Western Reserve University, Cleveland, Ohio, United States
3 shared publicationsAnkit Bhatia
Department of Anatomy and Cell Biology Wayne State University School of Medicine, Detroit, Michigan, United States
2 shared publications
Latest Publications
- Open Access
- 24 December 2025
- Published by Wiley in Alzheimer's & Dementia
- Vol. 21 (S2) , e101738
Abnormal light‐dependent retinal responses in early‐stage Alzheimer's disease
Background: Glia facilitate amyloid beta clearance, which is reduced Alzheimer's disease (ALZ). In a prior optical coherence tomography (OCT) study of the retina, some light‐dependent changes co‐localized with macroglia, irrespective of neuronal and vascular/avascular boundaries. That putative marker of glial function was subtly abnormal in later stages of Alzheimer's disease (DOI: 10.1016/j.neuroimage.2020.117022). For this study, we (1) hypothesized that the same changes occurred at early stages, before retinal structural changes, (2) explored whether Alzheimer's‐associated functional abnormalities varied with proximity to the fovea. Method: We compared OCT images from 24 eyes of 13 people at an early stage of biomarker‐confirmed Alzheimer's disease (“ALZ”) to images from 19 eyes of 10 people without Alzheimer's (biomarker‐negative control; “CON”). After measuring macular thicknesses and peripapillary retinal nerve fiber layer thicknesses, we collected functional data – imaging in the darkness versus after bright light exposure. B‐scan intensities were transformed into attenuation coefficient maps, which we aligned and spatially normalized to facilitate groupwise comparisons. Multilevel models were used to summarize light‐dependent changes in each retinal layer spanning between the fovea and the optic disc. Result: ALZ and CON groups well‐balanced for age, sex, and education, but had different scores on the Montreal Cognitive Assessment ( p p <0.0005). Both groups showed similar light responses over the rod and cone outer segments, but had significantly different (false discovery rate; q<0.05) functional responses in most other retinal layers; those occupied by macroglia. Group functional differences extended from cone‐only foveola through rod‐dominated perifovea, and were most robust 0.5‐1.0 mm from the foveal center. Conclusion: We find robust Alzheimer's‐related functional changes in the retina, but in an earlier disease stage than previously reported. The location of those changes implies a macroglial origin, rather than a primarily neural or primarily vascular origin.
- 24 December 2025
- Published by Wiley in Alzheimer's & Dementia
- Vol. 21 (S2) , e101738
Open AccessAbnormal light‐dependent retinal responses in early‐stage Alzheimer's disease
Background: Glia facilitate amyloid beta clearance, which is reduced Alzheimer's disease (ALZ). In a prior optical coherence tomography (OCT) study of the retina, some light‐dependent changes co‐localized with macroglia, irrespective of neuronal and vascular/avascular boundaries. That putative marker of glial function was subtly abnormal in later stages of Alzheimer's disease (DOI: 10.1016/j.neuroimage.2020.117022). For this study, we (1) hypothesized that the same changes occurred at early stages, before retinal structural changes, (2) explored whether Alzheimer's‐associated functional abnormalities varied with proximity to the fovea. Method: We compared OCT images from 24 eyes of 13 people at an early stage of biomarker‐confirmed Alzheimer's disease (“ALZ”) to images from 19 eyes of 10 people without Alzheimer's (biomarker‐negative control; “CON”). After measuring macular thicknesses and peripapillary retinal nerve fiber layer thicknesses, we collected functional data – imaging in the darkness versus after bright light exposure. B‐scan intensities were transformed into attenuation coefficient maps, which we aligned and spatially normalized to facilitate groupwise comparisons. Multilevel models were used to summarize light‐dependent changes in each retinal layer spanning between the fovea and the optic disc. Result: ALZ and CON groups well‐balanced for age, sex, and education, but had different scores on the Montreal Cognitive Assessment ( p p <0.0005). Both groups showed similar light responses over the rod and cone outer segments, but had significantly different (false discovery rate; q<0.05) functional responses in most other retinal layers; those occupied by macroglia. Group functional differences extended from cone‐only foveola through rod‐dominated perifovea, and were most robust 0.5‐1.0 mm from the foveal center. Conclusion: We find robust Alzheimer's‐related functional changes in the retina, but in an earlier disease stage than previously reported. The location of those changes implies a macroglial origin, rather than a primarily neural or primarily vascular origin.
- Open Access
- 10 June 2025
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 20 (6) , e0325217
Quantifying the influence of optical coherence tomography beam tilt in each retinal layer
Purpose: Well-aligned microstructures within the retina – like retinal nerve fiber layer (RNFL) axons – differentially reflect light depending on its angle. Our goal was to quantify the influence of optical coherence tomography (OCT) beam tilt on reflectivity of each layer of the mouse retina. Methods: We collected OCT images in a single plane capturing the optic nerve head, temporal retina, and nasal retina, while tilting the OCT beam at various angles. We converted signal intensities to estimated attenuation coefficients (eAC). The attenuation coefficient describes how quickly the remainder of an OCT beam’s light is absorbed or scattered at a given depth into the retina. A single-ellipse model based on prior literature was calculated at each retinal depth, describing the maximum eAC across all tilts (ellipse semi-major axis), the beam tilt eliciting that maximum eAC, and eAC’s dependence on beam tilt (semi-major versus semi-minor axes). Post hoc, the inner retina bore an unexpectedly complex relationship between beam tilt and eAC, which we explored with a two-ellipse model. Results: eACs in the temporal and nasal retina were dissimilar at specific beam tilts, but this was near-completely explained by differences in microstructure alignment. Dependence on beam tilt was substantial over the photoreceptors, but non-zero in all retinal layers. Post-hoc, two-ellipse models implied that microstructures vitread to the external limiting membrane were well-aligned with the photoreceptor inner and outer segments, and a small fraction (≥0.3%) of that tissue is especially translucent. Conclusion: We mapped microstructure alignment throughout the retina. Expected findings at the photoreceptor inner and outer segments are complemented by new evidence of unusually translucent microstructures spanning much of the retina, possibly representing Müller glia.
- 10 June 2025
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 20 (6) , e0325217
Open AccessQuantifying the influence of optical coherence tomography beam tilt in each retinal layer
Purpose: Well-aligned microstructures within the retina – like retinal nerve fiber layer (RNFL) axons – differentially reflect light depending on its angle. Our goal was to quantify the influence of optical coherence tomography (OCT) beam tilt on reflectivity of each layer of the mouse retina. Methods: We collected OCT images in a single plane capturing the optic nerve head, temporal retina, and nasal retina, while tilting the OCT beam at various angles. We converted signal intensities to estimated attenuation coefficients (eAC). The attenuation coefficient describes how quickly the remainder of an OCT beam’s light is absorbed or scattered at a given depth into the retina. A single-ellipse model based on prior literature was calculated at each retinal depth, describing the maximum eAC across all tilts (ellipse semi-major axis), the beam tilt eliciting that maximum eAC, and eAC’s dependence on beam tilt (semi-major versus semi-minor axes). Post hoc, the inner retina bore an unexpectedly complex relationship between beam tilt and eAC, which we explored with a two-ellipse model. Results: eACs in the temporal and nasal retina were dissimilar at specific beam tilts, but this was near-completely explained by differences in microstructure alignment. Dependence on beam tilt was substantial over the photoreceptors, but non-zero in all retinal layers. Post-hoc, two-ellipse models implied that microstructures vitread to the external limiting membrane were well-aligned with the photoreceptor inner and outer segments, and a small fraction (≥0.3%) of that tissue is especially translucent. Conclusion: We mapped microstructure alignment throughout the retina. Expected findings at the photoreceptor inner and outer segments are complemented by new evidence of unusually translucent microstructures spanning much of the retina, possibly representing Müller glia.
- Open Access
- 10 September 2021
- Published by Elsevier in JACEP Open
- Vol. 2 (5) , e12522
A clinical decision rule predicting outcomes of emergency department patients with altered mental status
- 10 September 2021
- Published by Elsevier in JACEP Open
- Vol. 2 (5) , e12522
Open AccessA clinical decision rule predicting outcomes of emergency department patients with altered mental status
- Open Access
- 1 October 2020
- Published by Elsevier in NeuroImage
- Vol. 219, 117022
Optical coherence tomography reveals light-dependent retinal responses in Alzheimer’s disease
- 1 October 2020
- Published by Elsevier in NeuroImage
- Vol. 219, 117022
Open AccessOptical coherence tomography reveals light-dependent retinal responses in Alzheimer’s disease
- Open Access
- 1 January 2020
- Published by Wiley in Alzheimer's & Dementia: Translational Research & Clinical Interventions
- Vol. 6 (1)
Validation of SATURN, a free, electronic, self‐administered cognitive screening test
Background: Cognitive screening is limited by clinician time and variability in administration and scoring. We therefore developed Self‐Administered Tasks Uncovering Risk of Neurodegeneration (SATURN), a free, public‐domain, self‐administered, and automatically scored cognitive screening test, and validated it on inexpensive (<$100) computer tablets. Methods: SATURN is a 30‐point test including orientation, word recall, and math items adapted from the Saint Louis University Mental Status test, modified versions of the Stroop and Trails tasks, and other assessments of visuospatial function and memory. English‐speaking neurology clinic patients and their partners 50 to 89 years of age were given SATURN, the Montreal Cognitive Assessment (MoCA), and a brief survey about test preferences. For patients recruited from dementia clinics (n = 23), clinical status was quantified with the Clinical Dementia Rating (CDR) scale. Care partners (n = 37) were assigned CDR = 0. Results: SATURN and MoCA scores were highly correlated ( P < .00001; r = 0.90). CDR sum‐of‐boxes scores were well‐correlated with both tests ( P < .00001) ( r = −0.83 and −0.86, respectively). Statistically, neither test was superior. Most participants (83%) reported that SATURN was easy to use, and most either preferred SATURN over the MoCA (47%) or had no preference (32%). Discussion: Performance on SATURN—a fully self‐administered and freely available (https://doi.org/10.5061/dryad.02v6wwpzr) cognitive screening test—is well‐correlated with MoCA and CDR scores.
- 1 January 2020
- Published by Wiley in Alzheimer's & Dementia: Translational Research & Clinical Interventions
- Vol. 6 (1)
Open AccessValidation of SATURN, a free, electronic, self‐administered cognitive screening test
Background: Cognitive screening is limited by clinician time and variability in administration and scoring. We therefore developed Self‐Administered Tasks Uncovering Risk of Neurodegeneration (SATURN), a free, public‐domain, self‐administered, and automatically scored cognitive screening test, and validated it on inexpensive (<$100) computer tablets. Methods: SATURN is a 30‐point test including orientation, word recall, and math items adapted from the Saint Louis University Mental Status test, modified versions of the Stroop and Trails tasks, and other assessments of visuospatial function and memory. English‐speaking neurology clinic patients and their partners 50 to 89 years of age were given SATURN, the Montreal Cognitive Assessment (MoCA), and a brief survey about test preferences. For patients recruited from dementia clinics (n = 23), clinical status was quantified with the Clinical Dementia Rating (CDR) scale. Care partners (n = 37) were assigned CDR = 0. Results: SATURN and MoCA scores were highly correlated ( P < .00001; r = 0.90). CDR sum‐of‐boxes scores were well‐correlated with both tests ( P < .00001) ( r = −0.83 and −0.86, respectively). Statistically, neither test was superior. Most participants (83%) reported that SATURN was easy to use, and most either preferred SATURN over the MoCA (47%) or had no preference (32%). Discussion: Performance on SATURN—a fully self‐administered and freely available (https://doi.org/10.5061/dryad.02v6wwpzr) cognitive screening test—is well‐correlated with MoCA and CDR scores.
- Open Access
- 26 March 2019
- Published by Wolters Kluwer Health in Neurology
- Vol. 92 (13) , 631-634
Global & Community Health: Brief in-hospital cognitive screening anticipates complex admissions and may detect dementia
Objective With the long-term goal of improving community health by screening for dementia, we tested the utility of integrating the Six-Item Screener (SIS) into our emergency department neurology consultations. Methods In this cross-sectional observational study, we measured SIS performance within 24 hours of hospital arrival in 100 consecutive English-speaking patients aged ≥45 years. Performance was compared to patient age, previously charted cognitive impairment, and proxies for in-hospital complexity: whether or not a patient was admitted to the hospital and the number of medical studies ordered. Results Those with poor SIS performance were older (p = 0.02) and more likely to have previously charted cognitive impairment (p < 0.01; sensitivity 86%, specificity 77%). Poor performers were more likely to be admitted to the hospital (p = 0.04; odds ratio 3.6) and were subjected to more tests once admitted (p < 0.01), relationships that persisted after accounting for age and history of cognitive impairment. Conclusions Poor performance on the SIS was associated with previously charted cognitive impairment, justifying future study of its ability to detect unrecognized dementia cases. Until then, its ability to inexpensively anticipate medically complex hospital admissions motivates broader emergency department use of the SIS.
- 26 March 2019
- Published by Wolters Kluwer Health in Neurology
- Vol. 92 (13) , 631-634
Open AccessGlobal & Community Health: Brief in-hospital cognitive screening anticipates complex admissions and may detect dementia
Objective With the long-term goal of improving community health by screening for dementia, we tested the utility of integrating the Six-Item Screener (SIS) into our emergency department neurology consultations. Methods In this cross-sectional observational study, we measured SIS performance within 24 hours of hospital arrival in 100 consecutive English-speaking patients aged ≥45 years. Performance was compared to patient age, previously charted cognitive impairment, and proxies for in-hospital complexity: whether or not a patient was admitted to the hospital and the number of medical studies ordered. Results Those with poor SIS performance were older (p = 0.02) and more likely to have previously charted cognitive impairment (p < 0.01; sensitivity 86%, specificity 77%). Poor performers were more likely to be admitted to the hospital (p = 0.04; odds ratio 3.6) and were subjected to more tests once admitted (p < 0.01), relationships that persisted after accounting for age and history of cognitive impairment. Conclusions Poor performance on the SIS was associated with previously charted cognitive impairment, justifying future study of its ability to detect unrecognized dementia cases. Until then, its ability to inexpensively anticipate medically complex hospital admissions motivates broader emergency department use of the SIS.
- 1 June 2017
- Published by Elsevier in Journal of Stroke and Cerebrovascular Diseases
- Vol. 26 (6) , e102-e104
Acute Stroke Despite Dabigatran Anticoagulation Treated with Idarucizumab and Intravenous Tissue Plasminogen Activator
- 1 June 2017
- Published by Elsevier in Journal of Stroke and Cerebrovascular Diseases
- Vol. 26 (6) , e102-e104
Acute Stroke Despite Dabigatran Anticoagulation Treated with Idarucizumab and Intravenous Tissue Plasminogen Activator
- 18 April 2017
- Published by Wolters Kluwer Health in Neurology
- Vol. 88 (16_supplem)
Development of an Algorithm for Treatment of Altered Mental Status in the Emergency Department (P2.202)
- 18 April 2017
- Published by Wolters Kluwer Health in Neurology
- Vol. 88 (16_supplem)
Development of an Algorithm for Treatment of Altered Mental Status in the Emergency Department (P2.202)
- 1 March 2016
- Published by Elsevier in Progress in Retinal and Eye Research
- Vol. 51, 90-106
MRI of rod cell compartment-specific function in disease and treatment in vivo
- 1 March 2016
- Published by Elsevier in Progress in Retinal and Eye Research
- Vol. 51, 90-106
MRI of rod cell compartment-specific function in disease and treatment in vivo
- Open Access
- 1 October 2015
- Published by Association for Research in Vision and Ophthalmology (ARVO) in Investigative Ophthalmology & Visual Science
- Vol. 56 (11) , 6294-6303
Systemic Retinaldehyde Treatment Corrects Retinal Oxidative Stress, Rod Dysfunction, and Impaired Visual Performance in Diabetic Mice
Purpose: Diabetes appears to induce a visual cycle defect because rod dysfunction is correctable with systemic treatment of the visual cycle chromophore 11-cis-retinaldehyde. However, later studies have found no evidence for visual cycle impairment. Here, we further examined whether photoreceptor dysfunction is corrected with 11-cis-retinaldehyde. Because antioxidants correct photoreceptor dysfunction in diabetes, the hypothesis that exogenous visual chromophores have antioxidant activity in the retina of diabetic mice in vivo was tested. Methods: Rod function in 2-month-old diabetic mice was evaluated using transretinal electrophysiology in excised retinas and apparent diffusion coefficient (ADC) MRI to measure light-evoked expansion of subretinal space (SRS) in vivo. Optokinetic tracking was used to evaluate cone-based visual performance. Retinal production of superoxide free radicals, generated mostly in rod cells, was biochemically measured with lucigenin. Diabetic mice were systemically treated with a single injection of either 11-cis-retinaldehyde, 9-cis-retinaldehyde (a chromophore surrogate), or all-trans-retinaldehyde (the photoisomerization product of 11-cis-retinaldehyde). Results: Consistent with previous reports, diabetes significantly reduced (1) dark-adapted rod photo responses (transretinal recording) by ∼18%, (2) rod-dominated light-stimulated SRS expansion (ADC MRI) by ∼21%, and (3) cone-dominated contrast sensitivity (using optokinetic tracking [OKT]) by ∼30%. Both 11-cis-retinaldehyde and 9-cis-retinaldehyde largely corrected these metrics of photoreceptor dysfunction. Higher-than-normal retinal superoxide production in diabetes by ∼55% was also significantly corrected following treatment with 11-cis-retinaldehyde, 9-cis-retinaldehyde, or all-trans-retinaldehyde. Conclusions: Collectively, data suggest that retinaldehydes improve photoreceptor dysfunction in diabetic mice, independent of the visual cycle, via an antioxidant mechanism.
- 1 October 2015
- Published by Association for Research in Vision and Ophthalmology (ARVO) in Investigative Ophthalmology & Visual Science
- Vol. 56 (11) , 6294-6303
Open AccessSystemic Retinaldehyde Treatment Corrects Retinal Oxidative Stress, Rod Dysfunction, and Impaired Visual Performance in Diabetic Mice
Purpose: Diabetes appears to induce a visual cycle defect because rod dysfunction is correctable with systemic treatment of the visual cycle chromophore 11-cis-retinaldehyde. However, later studies have found no evidence for visual cycle impairment. Here, we further examined whether photoreceptor dysfunction is corrected with 11-cis-retinaldehyde. Because antioxidants correct photoreceptor dysfunction in diabetes, the hypothesis that exogenous visual chromophores have antioxidant activity in the retina of diabetic mice in vivo was tested. Methods: Rod function in 2-month-old diabetic mice was evaluated using transretinal electrophysiology in excised retinas and apparent diffusion coefficient (ADC) MRI to measure light-evoked expansion of subretinal space (SRS) in vivo. Optokinetic tracking was used to evaluate cone-based visual performance. Retinal production of superoxide free radicals, generated mostly in rod cells, was biochemically measured with lucigenin. Diabetic mice were systemically treated with a single injection of either 11-cis-retinaldehyde, 9-cis-retinaldehyde (a chromophore surrogate), or all-trans-retinaldehyde (the photoisomerization product of 11-cis-retinaldehyde). Results: Consistent with previous reports, diabetes significantly reduced (1) dark-adapted rod photo responses (transretinal recording) by ∼18%, (2) rod-dominated light-stimulated SRS expansion (ADC MRI) by ∼21%, and (3) cone-dominated contrast sensitivity (using optokinetic tracking [OKT]) by ∼30%. Both 11-cis-retinaldehyde and 9-cis-retinaldehyde largely corrected these metrics of photoreceptor dysfunction. Higher-than-normal retinal superoxide production in diabetes by ∼55% was also significantly corrected following treatment with 11-cis-retinaldehyde, 9-cis-retinaldehyde, or all-trans-retinaldehyde. Conclusions: Collectively, data suggest that retinaldehydes improve photoreceptor dysfunction in diabetic mice, independent of the visual cycle, via an antioxidant mechanism.